We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 101-120 of 10,000 results
  1. A cervical cancer biorepository for pharmacogenomics research in Zimbabwe

    Background

    Research infrastructures such as biorepositories are essential to facilitate genomics and its growing applications in health research and...

    Oppah Kuguyo, Nyasha Chambwe, ... Alice Matimba in BMC Cancer
    Article Open access 16 December 2022
  2. Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

    Purpose

    This study aimed to analyse the genomic alteration profiles and immune characteristics of a cohort of Chinese cervical cancer patients to...

    Jing Liu, Zirong Li, ... Qin Xu in BMC Medical Genomics
    Article Open access 04 November 2022
  3. Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population

    Objective

    Mutations in the NLRP3gene have previously been linked to certain forms of cancer, but there have not been any specific studies examining...

    Qingchun Lu, Xiaoxia Lao, ... Zhige Yang in Infectious Agents and Cancer
    Article Open access 26 October 2023
  4. Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria

    Background

    High risk human papillomaviruses (HR-HPV) have a causal role in cervical oncogenesis, and HIV-mediated immune suppression allows HR-HPV to...

    Jonah Musa, Mamoudou Maiga, ... Supriya Dinesh Mehta in BMC Cancer
    Article Open access 20 July 2023
  5. Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review

    Background

    Cervical cancer is a preventable and treatable form of cancer yet continues to be the fourth most common cancer among women globally....

    Javiera Martinez-Gutierrez, Sophie Chima, ... Jon Emery in BMC Cancer
    Article Open access 12 July 2023
  6. Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria

    Introduction

    Invasive cervical cancer (ICC) is an HIV-associated cancer that is preventable and precancerous stages including early ICC stages could...

    Jonah Musa, Masha Kocherginsky, ... Melissa A. Simon in Infectious Agents and Cancer
    Article Open access 01 November 2023
  7. Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis

    Background

    Experts have proposed an ‘EVEN FASTER’ concept targeting age-groups maintaining circulation of human papillomavirus (HPV). We explored...

    Allison Portnoy, Kine Pedersen, ... Emily A. Burger in British Journal of Cancer
    Article 20 April 2024
  8. Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study

    Background

    Knowledge of risk factors and symptoms of cervical cancer has been found to promote uptake of screening of cervical cancer. Most...

    Carolyn Nakisige, Marlieke de Fouw, ... Jelle Stekelenburg in BMC Cancer
    Article Open access 11 April 2024
  9. MiR-1254 suppresses the proliferation and invasion of cervical cancer cells by modulating CD36

    Background

    This study aimed to elucidate the roles of miR-1254 in cervical cancer progression and to explore the underlying mechanisms.

    ...
    Jun Zhang, Xing Li, ... Yan Zhang in Journal of Translational Medicine
    Article Open access 26 August 2022
  10. The linkage of NF-κB signaling pathway-associated long non-coding RNAs with tumor microenvironment and prognosis in cervical cancer

    Background

    NF-κB signaling pathway participate closely in regulating inflammation and immune response in many cancers. Long non-coding RNAs (lncRNAs)...

    Xue Feng, Ru Shan, Xiaomeng Hu in BMC Medical Genomics
    Article Open access 17 July 2023
  11. Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town, Northeast Ethiopia

    Introduction

    Despite the higher burden of cervical cases, screening programs in highly affected developing countries remained low. This made the...

    Tilahun Assefa, Mastewal Arefaynie, ... Natnael Kebede in BMC Cancer
    Article Open access 20 December 2022
  12. FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer

    Background

    FAT4 (FAT Atypical Cadherin 4) is a member of the cadherin-associated protein family, which has been shown to function as a tumor...

    Dongying Wang, Shuying Wu, ... Tianmin Xu in Journal of Experimental & Clinical Cancer Research
    Article Open access 01 September 2023
  13. Cervical cancer screening and predictors of screening by diabetes status

    Purpose

    Women with diabetes have lower survival rates after a cervical cancer diagnosis compared to women without diabetes. Pap smears and human...

    Eric A. Miller, Paul F. Pinsky in Cancer Causes & Control
    Article 10 August 2022
  14. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells

    A number of studies have confirmed that Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ)-transcriptional...

    Shu Li, Xing Li, ... Su-fang Wu in Apoptosis
    Article Open access 29 March 2024
  15. DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test

    Background

    Cervical screening using primary human papilloma virus (HPV) testing and cytology is being implemented in several countries. Cytology as...

    Chiara Herzog, Karin Sundström, ... Martin Widschwendter in Clinical Epigenetics
    Article Open access 21 November 2022
  16. Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer

    Background

    Rather low vaccination rates for Human papillomavirus (HPV) and pre-existing cervical cancer patients with limited therapeutic strategies...

    Yuchong Yu, Yao Liu, ... Qiong Fan in Cancer Cell International
    Article Open access 15 May 2023
  17. Sociodemographic characteristics and their association with survival in women with cervical cancer

    Background

    In 2020, the highest incidence and mortality from cervical cancer (CC) were detected in low and middle-income countries. CC remains a...

    Lucely Cetina-Pérez, Julissa Luvián-Morales, ... Antonio Nateras in BMC Cancer
    Article Open access 01 February 2024
  18. Survival status and predictors of mortality among cervical cancer patients at oncologic centers in Addis Ababa, Ethiopia: a follow up study

    Background

    Cervical cancer (CC) ranks as the third most commonly diagnosed cancer and the fourth leading cause of cancer-related deaths among women...

    Samuel Dessu Sifer in BMC Cancer
    Article Open access 20 June 2024
  19. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer

    Background

    Cervical screening is transitioning from primary cytology to primary human papillomavirus (HPV) testing. HPV testing is highly sensitive...

    James E. Barrett, Karin Sundström, ... Martin Widschwendter in Genome Medicine
    Article Open access 19 October 2022
  20. Factors related to knowledge, attitudes, and behaviors regarding cervical cancer among Yemeni women

    Background

    Cervical cancer (CxCa), although preventable, is still among the most prevalent cancers in women. Mortality from this cancer is high,...

    Boshra Ali, Andrzej Galbarczyk, ... Hülya Gül in BMC Cancer
    Article Open access 06 June 2024
Did you find what you were looking for? Share feedback.